Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Epidemiology

• Publication date

  2013-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/aje/kwt109PMID 23997209PMCID PMC3792728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience.

  2012cited by this paper
• Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

  2012cited by this paper
• Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction

  2012cited by this paper
• Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

  2012cited by this paper
• Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993–2004: a study of 175 216 patients with a first acute myocardial infarction in Sweden

  2011cited by this paper
• Lifetime Costs of Medical Care After Heart Failure Diagnosis

  2011cited by this paper
• 30-year trends in heart failure in patients hospitalized with acute myocardial infarction.

  2011cited by this paper
• SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models

  2011cited by this paper
• Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction

  2011cited by this paper
• Abstract 17546: No Decrease in the Incidence of Heart Failure Following Acute Myocardial Infarction in the Years 1994-2006

  2011cited by this paper
• Association Between Myocardial Infarction and Fractures: An Emerging Phenomenon

  2011cited by this paper
• Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

  2011cited by this paper
• Population trends in the incidence and outcomes of acute myocardial infarction.

  2010cited by this paper
• Declining Severity of Myocardial Infarction From 1987 to 2002: The Atherosclerosis Risk in Communities (ARIC) Study

  2010cited by this paper
• Trends in Mortality of Acute Myocardial Infarction After Discharge From the Hospital

  2010cited by this paper
• Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond

  2010cited by this paper
• Myocardial infarction outcomes: "the times, they are a-changin...".

  2010cited by this paper
• Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction

  2010cited by this paper
• Declining Severity of Myocardial Infarction From 1987 to 2002: The Atherosclerosis Risk in Communities (ARIC) Study

  2009cited by this paper
• Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.

  2009cited by this paper
• [Sudden death after a myocardial infarction].

  2009cited by this paper
• Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction

  2009cited by this paper
• Imputing missing covariate values for the Cox model

  2009cited by this paper
• Sudden death after myocardial infarction.

  2008cited by this paper
• Heart failure after acute myocardial infarction: a lost battle in the war on heart failure?

  2008cited by this paper
• Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction

  2008influential reference
• Erratum to "A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model" [Computer Methods and Programs in Biomedicine 88 (2007) 95-101]

  2008cited by this paper
• Pioneers in cardiology: Vincent Dor, MD. Interview by Mark Nicholls.

  2007cited by this paper
• A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model

  2007cited by this paper
• Trends in prevalence and outcome of heart failure with preserved ejection fraction.

  2006cited by this paper
• Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

  2006cited by this paper
• Systolic and diastolic heart failure in the community.

  2006cited by this paper
• Evaluation of Valsartan, Captopril or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

  2005cited by this paper
• Valsartan, captopril, or both in myocardial infarction.

  2004cited by this paper
• Trends in heart failure incidence and survival in a community-based population.

  2004cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• Incidence of heart failure after myocardial infarction: is it changing over time?

  2003cited by this paper
• Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study.

  2003influential reference
• Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

  2001cited by this paper
• Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.

  2000cited by this paper
• Clinical predictors of heart failure in patients with first acute myocardial infarction.

  1999cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Chronic heart failure in the United States: a manifestation of coronary artery disease.

  1998cited by this paper
• Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

  1997cited by this paper
• History of the Rochester Epidemiology Project.

  1996influential reference
• A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

  1995cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• The natural history of congestive heart failure: the Framingham study.

  1971cited by this paper

• Prognostic value of N-terminal pro-B-type natriuretic peptide and C reactive protein testing in patients with acute ST-segment elevation myocardial infarction

  2026cites this paper
• Atherosclerotic features in patients with heart failure

  2025cites this paper
• Prognostic differences between persistent HFrEF and HFrecEF following acute myocardial infarction

  2025cites this paper
• A predictive model for heart failure with preserved ejection fraction following acute myocardial infarction: the HFpEF-AMI score

  2025cites this paper
• Machine learning algorithms to predict heart failure with preserved ejection fraction among patients with premature myocardial infarction

  2025cites this paper
• Clinical Predictors of Heart Failure after STEMI: Data from a Middle-Income Country with Limited Access to Percutaneous Coronary Intervention

  2025cites this paper
• Possibilities of Optimizing Drug Therapy for Myocardial Infarction: a Consensus on the Use of Type 2 Sodium-Glucose Co-Transporter Inhibitors. Conciliation Document of the Expert Group.

  2025cites this paper
• Incident heart failure and recurrent coronary events following acute myocardial infarction

  2025cites this paper
• Preditores Clínicos de Insuficiência Cardíaca após IAMCSST: Dados de um País de Renda Média com Acesso Limitado à Intervenção Coronária Percutânea

  2025cites this paper
• Myeloperoxidase induces monocyte migration and activation after acute myocardial infarction

  2024cites this paper
• Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI Registry: Healthcare Utilization after Myocardial Infarction.

  2024cites this paper
• Plasma biomarkers for predicting heart failure in patients with acute myocardial infarction

  2024cites this paper
• Macrophage heterogeneity in myocardial infarction: Evolution and implications for diverse therapeutic approaches

  2024cites this paper
• The Multifaceted Nature of Macrophages in Cardiovascular Disease

  2024cites this paper
• Impact of Sex in the Incidence of Heart Failure in Patients with Chronic Coronary Syndrome

  2024cites this paper
• Prognostic impact of heart failure admission in survivors of acute myocardial infarction

  2024cites this paper
• Noninvasive and Invasive Study of the Pumping Function of Rat Heart in Myocardial Infarction

  2024cites this paper
• The Role of Arterial Elasticity in Determining the Degree of Chronic Heart Failure in Myocardial Infarction.

  2023cites this paper
• The Compensatory Alterations оf the Relaxability and Distensibility of the Myocardium at Weakening of Its Contractility

  2023cites this paper
• Patients With AMI and Severely Reduced LVEF, a Well-Defined, Still Extremely Vulnerable Population (Insights from AMIS Plus Registry).

  2023cites this paper
• Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution

  2023cites this paper
• Myeloperoxidase PET Imaging Tracks Intracellular and Extracellular Treatment Changes in Experimental Myocardial Infarction

  2023cites this paper
• A Data‐Driven Analysis of Myocardial Tissue Contraction on Mild Transverse Aortic Constriction

  2023cites this paper
• Solid‐Phase Screening and Synthesis of Molecularly Imprinted Nanoparticles for Selective Recognition and Detection of Brain Natriuretic Peptide

  2023cites this paper
• ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department

  2023influential citation
• Macrophages in cardiac remodelling after myocardial infarction

  2023cites this paper
• Nrf2 attenuates the innate immune response after experimental myocardial infarction

  2022cites this paper
• Late Percutaneous Coronary Intervention is Associated with Better Prognosis of Patients with Acute Myocardial Infarction

  2022cites this paper
• Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?

  2022cites this paper
• Development and validation of a clinical predictive model for 1-year prognosis in coronary heart disease patients combine with acute heart failure

  2022cites this paper
• Heart failure with preserved ejection fraction in post myocardial infarction patients: a myocardial magnetic resonance (MR) tissue tracking study

  2022influential citation
• Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India

  2022cites this paper
• Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals

  2022cites this paper
• Frequency of acute heart failure in patients undergoing thrombolysis for anterior wall myocardial infarction.

  2022cites this paper
• MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure

  2021cites this paper
• Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction

  2021cites this paper
• Epidemiology of Heart Failure

  2021cites this paper
• Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure

  2020cites this paper
• Incidence, prognosis and predictors of heart failure after acute myocardial infarction

  2020cites this paper
• Effect of Elevated Pulmonary Artery Systolic Pressure on Short-Term Prognosis in Patients With Acute Myocardial Infarction

  2020cites this paper
• Prognostic value of D‐dimer in acute myocardial infarction complicated by heart failure with preserved ejection fraction

  2020cites this paper
• Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review

  2020cites this paper
• Heart failure after myocardial infarction: incidence and predictors

  2020cites this paper
• The Mid-term Mortality and Mode of Death in Survivors with ST-elevation Myocardial Infarction

  2020cites this paper
• REC: CardioClinics

  2020cites this paper
• Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs

  2019cites this paper
• Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus

  2019cites this paper
• Heart failure drug treatment.

  2019cites this paper
• Cardiac monocytes and macrophages after myocardial infarction

  2019cites this paper
• Temporal Trends in Heart Failure Following Myocardial Infarction : The Atherosclerotic Risk in Communities Study b . Abbreviated Title ( Length 26 characters ) : Heart Failure Following Myocardial Infarction 2

  2018influential citation
• Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.

  2018cites this paper
• Effect of Tivorel on the level of matrix metalloproteinases-2 and 9, galectin-3, final glycation products and functional state of the endothelium in patients with postinfarction chronic heart failure with preserved ejection fraction

  2018cites this paper
• Echocardiographic diastolic function evolution in patients with an anterior Q‐wave myocardial infarction: insights from the REVE‐2 study

  2018cites this paper
• Heart failure with reduced ejection fraction: A review of clinical status and meta-analyses of diagnosis by 3D echocardiography and natriuretic peptides-guided heart failure therapy

  2018cites this paper
• Cerebral blood flow alteration following acute myocardial infarction in mice

  2018cites this paper
• In the search for an ideal registry: Does the cloud have a silver lining?

  2018cites this paper
• Predictors and prognosis for incident in-hospital heart failure in patients with preserved ejection fraction after first acute myocardial infarction

  2018cites this paper
• B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.

  2018cites this paper
• Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study

  2018cites this paper
• Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease

  2017cites this paper
• PreSERVE-AMINovelty and Significance

  2017cites this paper
• Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure

  2017cites this paper
• Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study

  2017cites this paper
• Prognostic Value of Chronic Kidney Disease Measures in Patients With Cardiac Disease.

  2017cites this paper
• Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals

  2017cites this paper
• National Trends in the Incidence, Management, and Outcomes of Heart Failure Complications in Patients Hospitalized for ST-Segment Elevation Myocardial Infarction

  2017cites this paper
• Risk and predictors of readmission for heart failure following a myocardial infarction between 2004 and 2013: A Swedish nationwide observational study.

  2017cites this paper
• A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction

  2017cites this paper
• Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk

  2017cites this paper
• Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes.

  2017cites this paper
• Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis).

  2016cites this paper
• Carga de enfermedad de la insuficiencia cardiaca en América Latina: revisión sistemática y metanálisis

  2016cites this paper
• Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction

  2016cites this paper
• Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium

  2016cites this paper
• Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective

  2016cites this paper
• Burden of Heart Failure in Latin America: A Systematic Review and Meta-analysis.

  2016cites this paper
• Associations of high HDL cholesterol level with all-cause mortality in patients with heart failure complicating coronary heart disease

  2016influential citation
• Atherosclerotic Burden and Heart Failure After Myocardial Infarction.

  2016cites this paper
• Multimorbidity in heart failure: a community perspective.

  2015cites this paper
• End-systolic wall stress predicts post-discharge heart failure after acute myocardial infarction.

  2015cites this paper
• A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.

  2015cites this paper
• Metformin and preservation of left ventricular function

  2015cites this paper
• Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction

  2015cites this paper
• Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.

  2014cites this paper
• Clinical Track Methods and Results: Patients Who Underwent Successful Stenting for Stemi and Had Left Ventricular Dysfunction Conclusions: This Preserve-ami (phase 2, Randomized, Double-blind, Placebo-controlled Trial) Represents the Largest Study of Cell-based Therapy for Stemi Completed in the Uni

  year unknowncites this paper